These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31916845)

  • 1. Knockdown of
    Liu L; Cui Z; Zhang J; Wang J; Gu S; Ma J; Chen H; Hang L; Yang J; Shi Y
    Cancer Biother Radiopharm; 2020 Feb; 35(1):41-49. PubMed ID: 31916845
    [No Abstract]   [Full Text] [Related]  

  • 2. NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis.
    Yang Q; Pan Q; Li C; Xu Y; Wen C; Sun F
    Cell Death Differ; 2016 Aug; 23(8):1406-16. PubMed ID: 27035619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage.
    Zhen N; Jin L; Ma J; Zhu J; Gu S; Wang J; Pan Q; Ni X; Xu M
    Anticancer Drugs; 2018 Sep; 29(8):756-766. PubMed ID: 29952772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.
    Yang Q; Ou C; Liu M; Xiao W; Wen C; Sun F
    Carcinogenesis; 2014 Jul; 35(7):1643-51. PubMed ID: 24710624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoorientin triggers apoptosis of hepatoblastoma by inducing DNA double-strand breaks and suppressing homologous recombination repair.
    Huang D; Jin L; Li Z; Wu J; Zhang N; Zhou D; Ni X; Hou T
    Biomed Pharmacother; 2018 May; 101():719-728. PubMed ID: 29524880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.
    Pei Y; Yao Q; Yuan S; Xie B; Liu Y; Ye C; Zhuo H
    Oncotarget; 2016 Nov; 7(47):77890-77901. PubMed ID: 27788486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
    Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
    Kang J; Chung KC
    Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the ERK pathway.
    Zhang H; Wu G; Chen B
    Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between NRAGE and the radioresistance of esophageal carcinoma cell line TE13R120.
    Xue XY; Liu ZH; Jing FM; Li YG; Liu HZ; Gao XS
    Chin J Cancer; 2010 Oct; 29(10):900-6. PubMed ID: 20868560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NRAGE subcellular location and epithelial-mesenchymal transition on radiation resistance of esophageal carcinoma cell.
    Chang X; Xue X; Zhang Y; Zhang G; Zhou H; Yang Y; Ran Y; Xiao Z; Ge X; Liu H
    J Cancer Res Ther; 2018 Jan; 14(1):46-51. PubMed ID: 29516958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
    Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
    Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of NRAGE induces autophagy via AMPK/Ulk1/Atg13 signaling pathway in NSCLC cells.
    Zhou Y; Huang N; Wu J; Zhen N; Li N; Li Y; Li YX
    Tumour Biol; 2017 Jun; 39(6):1010428317709676. PubMed ID: 28639909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neurotrophin receptor-mediated MAGE homology on proliferation and odontoblastic differentiation of mouse dental pulp cells.
    Qi S; Wu Q; Ma J; Li J; Chen F; Xu Y; Pan Q; Wang R
    Cell Prolif; 2015 Apr; 48(2):221-30. PubMed ID: 25736627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma.
    Li L; Wu Y; Huang HT; Yong JK; Lv Z; Zhou Y; Xiang X; Zhao J; Xi Z; Feng H; Xia Q
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):377. PubMed ID: 39085725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
    Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R
    Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
    Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
    Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
    Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
    Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.